Skip to main content

previous disabled Page of 3
and
  1. Article

    Adjuvant chemotherapy for operable breast cancer: old vs new schema

    P Valagussa, L Gianni, G Bonadonna in Breast Cancer Research (2005)

  2. No Access

    Article

    Double-Peaked Time Distribution of Mortality for Breast Cancer Patients Undergoing Mastectomy

    Purpose. To gather information on the natural history of breast cancer from the time-distribution of deaths of patients undergoing mastectomy alone.

    R. Demicheli, P. Valagussa, G. Bonadonna in Breast Cancer Research and Treatment (2002)

  3. No Access

    Article

    Phase I/II study of gemcitabine in association with vinorelbine for metastatic breast cancer

    Background. Gemcitabine (G) and vinorelbine (V) have favorable safety profile and antitumor activity in metastatic breast cancer. To exploit their different mechanism of action and lack of overlap** toxicity, ...

    G. Mariani, P. Tagliabue, P. Zucchinelli in Breast Cancer Research and Treatment (2001)

  4. Article

    Open Access

    Does surgery modify growth kinetics of breast cancer micrometastases?

    Surgery should be considered as a major perturbing factor for metastasis development in laboratory animals. The different time distribution of mortality for 1173 patients undergoing mastectomy in comparison wi...

    R Demicheli, P Valagussa, G Bonadonna in British Journal of Cancer (2001)

  5. No Access

    Article

    Elevated pretreatment serum levels of Il-10 are associated with a poor prognosis in hodgkin's disease, the Milan Cancer Institute Experience

    Alterated cytokine secretion may play a role in determining Hodgkin's disease-related immunosuppression. The aim of this study was to analyze the clinical significance of interleukin-10(IL-10) serum levels in ...

    S. Viviani, P Notti, V Bonfante, P Verderio, P Valagussa, G Bonadonna in Medical Oncology (2000)

  6. No Access

    Article

    Soluble interleukin-2 receptors (sIL-2R) in Hodgkin's disease: outcome and clinical implications

    The aim of this study was to assess the prognostic role of soluble interleukin-2 receptors (sIL-2R) in Hodgkin's disease (HD) both in the achievement of complete remission (CR) and in predicting disease relaps...

    S Viviani, E Camerini, V Bonfante, A Santoro, M Balzarotti in British Journal of Cancer (1998)

  7. No Access

    Chapter and Conference Paper

    Putting Taxanes to Work in Operable Breast Cancer: A Search for Selective Indications from Empirical Studies

    Based on their unique and novel mechanism of action, the taxanes paclitaxel (PCT) and docetaxel (DCT) have been extensively studied in solid tumors. The two drugs found in the field of breast cancer an arena o...

    L. Gianni, G. Capri, P. Valagussa in Adjuvant Therapy of Primary Breast Cancer … (1998)

  8. No Access

    Article

    Five-day infusion fluorouracil plus vinorelbine i.v. in metastatic pretreated breast cancer patients

    The aim of the present study was to evaluate the clinical activity and side effects of a combination chemotherapy consisting of a five-day continuous infusion of fluorouracil and i.v. vinorelbine in metastatic...

    M. Zambetti, R. Demicheli, D. De Candis in Breast Cancer Research and Treatment (1997)

  9. No Access

    Chapter and Conference Paper

    Future Developments in Adjuvant Systemic Therapy for High-Risk Breast Cancer

    In an article written by B. Fisher (1984), the following statement can be found: “Competing forces have continuously played a role in determining the management of breast cancer.” This statement should remind ...

    G. Bonadonna in Adjuvant Therapy of Breast Cancer V (1996)

  10. No Access

    Chapter and Conference Paper

    Reproductive Potential After Adjuvant Chemotherapy for Breast Cancer

    The 10-year update of the world-wide overview of breast cancer treatment (Early Breast Cancer Trialists’ Collaborative Group 1992) has confirmed that adjuvant systemic therapy can alter the course of breast ca...

    P. Valagussa, D. De Candis, G. Antonelli in Adjuvant Therapy of Breast Cancer V (1996)

  11. No Access

    Article

    Serum LP(A) levels in randomized healthy men from different European countries

    Serum lipoprotein(a) [Lp(a) ], blood lipids, serum insulin and anthropometric parameters were determined in randomized samples of 38-year-old men living in six European cities: Ede (The Netherlands), Deinze (Belg...

    M. Cigolini, J. C. Seidell, M. G. Zenti, G. Bonadonna in European Journal of Epidemiology (1993)

  12. No Access

    Chapter and Conference Paper

    Long-Term Sequelae from Adjuvant Chemotherapy

    It has been estimated that 5000000 Americans living in 1987 have had cancer at some time during their lives, and that 3000000 have survived 5 years or longer, largely because of improvement in early detection ...

    P. Valagussa, A. Moliterni, M. Zambetti in Adjuvant Therapy of Breast Cancer IV (1993)

  13. No Access

    Chapter and Conference Paper

    Primary Chemotherapy for Resectable Breast Cancer

    Primary (neoadjuvant, preoperative) chemotherapy for surgically curative breast cancer is a novel treatment approach. The sequentially combined strategy derives from prior experience achieved with locally adva...

    G. Bonadonna, U. Veronesi, C. Brambilla, L. Ferrari in Adjuvant Therapy of Breast Cancer IV (1993)

  14. No Access

    Chapter and Conference Paper

    What Did We Learn from the Results of the International Overview about the Effects of Endocrine Therapy?

    The simple answer to the question posed in the title to this chapter is that we have learned, as already expected, that adjuvant endocrine therapy is effective. Indeed, both ovarian ablation and tamoxifen have...

    G. Bonadonna in Adjuvant Therapy of Breast Cancer IV (1993)

  15. No Access

    Chapter and Conference Paper

    Primary chemotherapy and surgery in advanced oral cavity squamous cell carcinomas : retrospective analysis

    Chemotherapy is usually employed for head and neck squamous cell carcinomas only in the advanced disease setting. The best regimen has not yet been defined, due to the lack of controlled trials and to differen...

    L. Licitra, C. Grandi, V. Bonfante in Proceedings of the 3rd International Congr… (1991)

  16. No Access

    Chapter

    Adjuvant Chemotherapy Programs in Node-Negative Breast Cancer

    Traditionally, women with node-negative breast cancer have been regarded as having a relatively favorable prognosis following locoregional therapy (surgery and/or radiotherapy) although for more than 10 years ...

    P. Valagussa, R. Silvestrini, G. Bonadonna in High-Risk Breast Cancer (1991)

  17. No Access

    Chapter and Conference Paper

    Combined approach to malignant small round blue cell neoplasms in the adult

    Small round blue cell neoplasms are common malignancies in the childhood but are rare in the adults. They include Ewing’s sarcoma, peripheral neuroepithelioma, and rhabdomyosarcoma. Ewing’s sarcoma

    P. Casali, P. Zucchinelli, A. Santoro in Proceedings of the 3rd International Congr… (1991)

  18. No Access

    Chapter and Conference Paper

    Recombinant Human GM-CSF for Large-Scale Collection of Circulating Hematopoietic Progenitors in Cancer Patients Treated with High-Dose Cyclophosphamide

    Experimental evidences indicate that human hematopoietic stem cells belong to a subset of undifferentiated bone marrow cells expressing a surface membrane glycoprotein of 110–120 kDa designated CD34 antigen [1...

    S. Siena, M. Bregni, F. Ravagnani, B. Brando in Cytokines in Hemopoiesis, Oncology, and AI… (1990)

  19. No Access

    Chapter and Conference Paper

    Hodgkin’s Disease: The Milan Cancer Institute Experience with MOPP and ABVD

    This paper briefly reports the Milan Cancer Institute experience on Hodgkin’s disease treated with an Adriamycin- and bleomycin-based combination (ABVD: Adriamycin, bleomycin, vinblastine, and dacarbazine). Fo...

    G. Bonadonna, P. Valagussa, A. Santoro in New Aspects in the Diagnosis and Treatment… (1989)

  20. No Access

    Chapter and Conference Paper

    Adjuvant Chemotherapy for Node-Negative Breast Cancer Patients

    Recent results have confirmed that adjuvant systemic therapies increase the relapse-free survival (RFS) and overall survival (OS) of patients with resectable breast cancer (Bonadonna and Valagussa 1988; Early ...

    G. Bonadonna, M. Zambetti, P. Valagussa in Adjuvant Therapy of Primary Breast Cancer (1989)

previous disabled Page of 3